Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in increased expression of MAP2K6 mRNA | increases expression | 18648102
|
C090942 |
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole |
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [MAP2K6 protein results in decreased expression of EP300 protein] | decreases expression|decreases reaction | 15767673
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of MAP2K6 mRNA | affects expression | 17562736
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of MAP2K6 protein | affects expression | 20106945
|
C412373 |
AG 1879 |
AG 1879 inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAP2K6 protein] | decreases reaction|increases phosphorylation | 20181660
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of MAP2K6 mRNA | affects expression | 16483693
|
D001149 |
Arsenates |
Arsenates results in decreased expression of MAP2K6 mRNA | decreases expression | 12773770
|
C006632 |
arsenic trioxide |
arsenic trioxide results in increased phosphorylation of and results in increased activity of MAP2K6 protein | increases activity|increases phosphorylation | 16818652
|
C006632 |
arsenic trioxide |
MAP2K6 protein affects the susceptibility to arsenic trioxide | affects response to substance | 16818652
|
C006632 |
arsenic trioxide |
MAP2K6 protein promotes the reaction [arsenic trioxide results in increased phosphorylation of and results in increased activity of MAPK14 protein] | increases activity|increases phosphorylation|increases reaction | 16818652
|
C015001 |
arsenite |
arsenite results in increased expression of MAP2K6 mRNA | increases expression | 18191166
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite results in decreased expression of MAP2K6 mRNA | decreases expression | 18687144
|
D001205 |
Ascorbic Acid |
Ascorbic Acid inhibits the reaction [Fenretinide results in increased phosphorylation of MAP2K6 protein] | decreases reaction|increases phosphorylation | 16407847
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of MAP2K6 mRNA | decreases expression | 20106945
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased phosphorylation of MAP2K6 protein | increases phosphorylation | 17003459
|
D019256 |
Cadmium Chloride |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MAP2K6 mRNA | affects cotreatment|decreases expression | 12634122
|
C023600 |
chromium oxide |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MAP2K6 mRNA | affects cotreatment|decreases expression | 12634122
|
C017133 |
chromous chloride |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MAP2K6 mRNA | affects cotreatment|decreases expression | 12634122
|
D003314 |
Corn Oil |
Corn Oil affects the expression of MAP2K6 mRNA | affects expression | 16360708
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of MAP2K6 mRNA | decreases expression | 20106945
|
C007262 |
deoxynivalenol |
AG 1879 inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAP2K6 protein] | decreases reaction|increases phosphorylation | 20181660
|
C007262 |
deoxynivalenol |
deoxynivalenol results in increased phosphorylation of MAP2K6 protein | increases phosphorylation | 20181660
|
D002945 |
Cisplatin |
MAP2K6 protein affects the susceptibility to Cisplatin | affects response to substance | 16217747
|
D004317 |
Doxorubicin |
Doxorubicin affects the activity of MAP2K6 protein | affects activity | 15870702
|
D004958 |
Estradiol |
[Progesterone co-treated with Estradiol] results in increased expression of MAP2K6 mRNA | affects cotreatment|increases expression | 17404688
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of MAP2K6 mRNA | decreases expression | 15834898
|
C020748 |
ferrous sulfate |
ferrous sulfate promotes the reaction [MAP3K7 protein results in increased phosphorylation of MAP2K6 protein] | increases phosphorylation|increases reaction | 17172471
|
C020748 |
ferrous sulfate |
ferrous sulfate results in increased phosphorylation of MAP2K6 protein | increases phosphorylation | 17172471
|
C020748 |
ferrous sulfate |
Filipin inhibits the reaction [ferrous sulfate promotes the reaction [MAP3K7 protein results in increased phosphorylation of MAP2K6 protein]] | decreases reaction|increases phosphorylation|increases reaction | 17172471
|
C020748 |
ferrous sulfate |
Filipin inhibits the reaction [ferrous sulfate results in increased phosphorylation of MAP2K6 protein] | decreases reaction|increases phosphorylation | 17172471
|
D005372 |
Filipin |
Filipin inhibits the reaction [ferrous sulfate promotes the reaction [MAP3K7 protein results in increased phosphorylation of MAP2K6 protein]] | decreases reaction|increases phosphorylation|increases reaction | 17172471
|
D005372 |
Filipin |
Filipin inhibits the reaction [ferrous sulfate results in increased phosphorylation of MAP2K6 protein] | decreases reaction|increases phosphorylation | 17172471
|
D005372 |
Filipin |
Filipin inhibits the reaction [Iron promotes the reaction [MAP3K7 protein results in increased phosphorylation of MAP2K6 protein]] | decreases reaction|increases phosphorylation|increases reaction | 17172471
|
D005372 |
Filipin |
Filipin inhibits the reaction [Iron results in increased phosphorylation of MAP2K6 protein] | decreases reaction|increases phosphorylation | 17172471
|
D017313 |
Fenretinide |
Ascorbic Acid inhibits the reaction [Fenretinide results in increased phosphorylation of MAP2K6 protein] | decreases reaction|increases phosphorylation | 16407847
|
D017313 |
Fenretinide |
Fenretinide results in increased phosphorylation of MAP2K6 protein | increases phosphorylation | 16407847
|
D007501 |
Iron |
Filipin inhibits the reaction [Iron promotes the reaction [MAP3K7 protein results in increased phosphorylation of MAP2K6 protein]] | decreases reaction|increases phosphorylation|increases reaction | 17172471
|
D007501 |
Iron |
Filipin inhibits the reaction [Iron results in increased phosphorylation of MAP2K6 protein] | decreases reaction|increases phosphorylation | 17172471
|
D007501 |
Iron |
Iron promotes the reaction [MAP3K7 protein results in increased phosphorylation of MAP2K6 protein] | increases phosphorylation|increases reaction | 17172471
|
D007501 |
Iron |
Iron results in increased phosphorylation of MAP2K6 protein | increases phosphorylation | 17172471
|
C008261 |
lead acetate |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MAP2K6 mRNA | affects cotreatment|decreases expression | 12634122
|
C015329 |
lycopene |
lycopene results in decreased expression of MAP2K6 protein | decreases expression | 17337101
|
D019216 |
Metals, Heavy |
Metals, Heavy results in decreased expression of MAP2K6 mRNA | decreases expression | 12773770
|
D008727 |
Methotrexate |
MAP2K6 protein affects the susceptibility to Methotrexate | affects response to substance | 16217747
|
D009151 |
Mustard Gas |
Mustard Gas results in increased phosphorylation of MAP2K6 protein | increases phosphorylation | 15251176
|
D009151 |
Mustard Gas |
Mustard Gas affects the expression of MAP2K6 mRNA | affects expression | 15651846
|
C014707 |
nitrosobenzylmethylamine |
nitrosobenzylmethylamine results in decreased expression of MAP2K6 mRNA | decreases expression | 17616710
|
D010634 |
Phenobarbital |
Phenobarbital results in increased expression of MAP2K6 mRNA | increases expression | 19270015
|
D011374 |
Progesterone |
[Progesterone co-treated with Estradiol] results in increased expression of MAP2K6 mRNA | affects cotreatment|increases expression | 17404688
|
D011374 |
Progesterone |
Progesterone results in increased expression of MAP2K6 mRNA | increases expression | 17404688
|
C093642 |
SB 203580 |
SB 203580 inhibits the reaction [MAP2K6 protein results in decreased expression of EP300 protein] | decreases expression|decreases reaction | 15767673
|
C017947 |
sodium arsenite |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MAP2K6 mRNA | affects cotreatment|decreases expression | 12634122
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of MAP2K6 mRNA | increases expression | 17879257
|
D018038 |
Sodium Selenite |
Sodium Selenite results in decreased expression of MAP2K6 mRNA | decreases expression | 16705456
|
D018038 |
Sodium Selenite |
Sodium Selenite results in increased expression of MAP2K6 mRNA | increases expression | 18175754
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of MAP2K6 mRNA | decreases expression | 14708085
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Methotrexate |
11.95 | 12039119 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
11.95 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
11.95 | 15322242 14514962 11752688 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.15 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.53 | 17505938 |
MESH:D058186 |
Acute Kidney Injury |
|
Cisplatin |
3.60 | 15814532 17670903 12690470 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
19.06 | 11798837 19825857 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
19.06 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Cisplatin |
19.06 | 17638652 11798837 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
19.06 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
19.06 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
19.06 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Fenretinide |
19.06 | 10697514 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
5.79 | 3712494 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
5.79 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
8.73 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
8.73 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.28 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.49 | 16712894 17306315 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.16 | 21441931 |
MESH:D019896 |
alpha 1-Antitrypsin Deficiency |
|
Iron |
5.24 | 16640825 |
MESH:D000544 |
Alzheimer Disease |
|
Iron |
4.88 | 16640825 16563566 |
MESH:D000544 |
Alzheimer Disease |
|
Metals, Heavy |
4.88 | 17430250 |
MESH:D000740 |
Anemia |
|
Iron |
7.76 | 16434484 16566752 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
7.76 | 11748828 |
MESH:D018798 |
Anemia, Iron-Deficiency |
|
Iron |
4.30 | 16569441 17163184 17375513 17147795 17162259 |
MESH:D000756 |
Anemia, Sideroblastic |
|
Iron |
4.45 | 16910769 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.43 | 10982225 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.68 | 19183758 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Iron |
4.02 | 16604332 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.07 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.41 | 15885639 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Methotrexate |
3.00 | 17286800 |
MESH:D001249 |
Asthma |
|
Mustard Gas |
2.58 | 10378619 |
MESH:D001260 |
Ataxia Telangiectasia |
|
Iron |
5.04 | 15336622 |
MESH:D050197 |
Atherosclerosis |
|
Iron |
3.47 | 16632123 16640825 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
2.14 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Iron |
2.14 | 17352947 |
MESH:D001327 |
Autoimmune Diseases |
|
Metals, Heavy |
5.79 | 16045731 |
MESH:D001424 |
Bacterial Infections |
|
Iron |
4.79 | 16640825 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.60 | 1440618 11289319 |
MESH:D001768 |
Blister |
|
Mustard Gas |
4.75 | 19167455 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
13.47 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
ferrous sulfate |
13.47 | 6421970 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
13.47 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.38 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.50 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Cisplatin |
10.68 | 14601052 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
10.68 | 14601052 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
4.92 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
3.86 | 15665606 15380490 15845082 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
7.95 | 17150277 |
MESH:D001932 |
Brain Neoplasms |
|
Fenretinide |
7.95 | 16187019 |
MESH:D001943 |
Breast Neoplasms |
|
Ascorbic Acid |
5.36 | 16443354 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
5.36 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
Cisplatin |
5.36 | 18382427 19526202 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
5.36 | 15994142 15136595 18382427 19526202 16322301 18628466 15567936 18695136 16264153 16096432 16595493 16115903 17426702 15939500 18234424 17369602 15993339 11325840 16935488 17983394 16826403 15692762 15668708 15634643 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
5.36 | 17289903 16675129 12948864 14630087 17018787 19861407 18497071 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
Fenretinide |
5.36 | 16601279 |
MESH:D001943 |
Breast Neoplasms |
|
Methotrexate |
5.36 | 16978400 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
5.36 | 15562024 17614352 16175315 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
5.36 | 20435547 |
MESH:D001989 |
Bronchiolitis Obliterans |
|
Mustard Gas |
4.75 | 15286001 |
MESH:D029481 |
Bronchitis, Chronic |
|
Mustard Gas |
4.56 | 17687719 10378619 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
3.95 | 11589617 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.06 | 16111702 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.40 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.48 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
21.26 | 3581430 7296757 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
21.26 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
21.26 | 21507988 12619106 12907637 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
21.26 | 14691202 16217749 15073043 11135700 15553829 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cisplatin |
21.26 | 17982673 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
21.26 | 18059187 17876044 16023760 16234567 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
21.26 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fenretinide |
21.26 | 17159502 16270382 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
21.26 | 20007298 17173139 20935162 1701930 6705139 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
21.26 | 17306315 16507464 15276417 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Cisplatin |
2.89 | 12023789 16685392 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.46 | 19014326 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
5.88 | 7296757 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
5.88 | 16201981 1485588 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
3.76 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
12.93 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Cisplatin |
12.93 | 17066447 6189445 18337622 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
12.93 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fenretinide |
12.93 | 16274795 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
12.93 | 18572023 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.14 | 18670907 16120746 18850075 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
7.26 | 17974986 16364871 17924179 17351982 15811867 16455267 16731534 18627295 16242529 17329180 16952015 17519947 17007740 15476868 16612575 17131338 17928571 17308081 15792986 16651473 16278810 16109756 17382496 15505089 16269455 |
MESH:D009202 |
Cardiomyopathies |
|
Iron |
7.26 | 16640825 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
5.68 | 17334414 16243910 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Iron |
5.68 | 16604332 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.34 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
13.69 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
13.69 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
13.69 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
13.69 | 19524636 20056578 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
3.85 | 4080065 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Fenretinide |
5.07 | 16154183 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.82 | 16835633 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
11.64 | 19486331 9022650 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
11.64 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
11.64 | 17333356 15861022 16919318 16105132 17681005 11677210 17110522 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
4.35 | 15894690 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
1.93 | 16354765 15340226 12621046 15668235 8697196 |
MESH:D003110 |
Colonic Neoplasms |
therapeutic |
|
| 15037631 |
MESH:D003110 |
Colonic Neoplasms |
|
arsenite |
3.91 | 15037631 |
MESH:D003110 |
Colonic Neoplasms |
|
Iron |
3.91 | 16640825 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
4.48 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
Cisplatin |
4.48 | 15273666 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
4.48 | 18259882 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fenretinide |
4.48 | 17273769 |
MESH:D003139 |
Common Cold |
|
Ascorbic Acid |
5.06 | 17323712 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.72 | 17141729 14669216 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
3.80 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
5.06 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
lead acetate |
5.06 | 19769572 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Methotrexate |
5.06 | 12039119 9562676 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
5.06 | 10048152 15322242 20055451 |
MESH:D003550 |
Cystic Fibrosis |
|
Methotrexate |
3.89 | 19747007 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.72 | 15213294 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.43 | 2524372 11906362 11298694 12868966 8970840 8156756 14531868 18759878 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.12 | 3621924 2952479 |
MESH:D003882 |
Dermatomyositis |
|
Methotrexate |
4.74 | 20191521 |
MESH:D003920 |
Diabetes Mellitus |
|
Iron |
8.35 | 16640825 16604332 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
8.35 | 16285004 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Iron |
3.23 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Ascorbic Acid |
6.63 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Iron |
6.63 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
6.63 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.07 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.09 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
10.55 | 9328219 6679447 6482804 18289764 1440618 18692083 8291058 16192314 9653073 7440962 11289319 18648102 9022650 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
10.55 | 19416960 16177239 11461765 16781746 15619225 11421492 10663392 17522070 11739529 14725611 12540782 17906064 11529661 12392966 10774834 19085960 19420014 12705907 2444490 16393943 19370779 10915739 14550746 14986274 18713872 18071297 16485898 12958197 11743745 16081117 19923254 16227642 19739265 11287661 12594235 11834606 17562736 16109766 19164858 15968718 12153990 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
10.55 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
10.55 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
10.55 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.68 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Cisplatin |
12.03 | 15033597 12649298 19839026 12231392 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
12.03 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
12.03 | 11462148 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
3.63 | 1851702 |
MESH:C538011 |
Eales disease |
|
Ascorbic Acid |
5.06 | 9068938 |
MESH:D004487 |
Edema |
|
Mustard Gas |
5.66 | 11428647 9260866 11428631 11402378 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
5.66 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.49 | 15322242 18230668 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
7.76 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
7.76 | 17692515 |
MESH:D016643 |
Encephalopathy, Bovine Spongiform |
|
Metals, Heavy |
6.90 | 16481041 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
6.64 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
6.64 | 18566989 11473722 19148513 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
7.76 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
7.76 | 9294722 10568697 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
4.74 | 18037988 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
3.71 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
3.46 | 3922381 11558140 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
2.68 | 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.20 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
3.85 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
3.61 | 3659116 |
MESH:D004890 |
Erythema |
|
Mustard Gas |
4.75 | 9357497 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
12.55 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
12.55 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
12.55 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Cisplatin |
12.55 | 17638652 15464296 16481741 15173087 16785472 |
MESH:D004938 |
Esophageal Neoplasms |
|
nitrosobenzylmethylamine |
12.55 | 15547733 16805852 15623463 15547721 15264214 15878914 16510608 15150132 16704527 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.71 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
20.83 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
arsenite |
20.83 | 18296743 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
20.83 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
20.83 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Iron |
20.83 | 16640825 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.06 | 11858732 |
MESH:D005317 |
Fetal Growth Retardation |
|
lead acetate |
5.00 | 19769572 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.60 | 6705139 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.18 | 19069698 |
MESH:D005355 |
Fibrosis |
|
arsenite |
12.50 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
12.50 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
12.50 | 20067830 |
MESH:D005621 |
Friedreich Ataxia |
|
Iron |
5.03 | 16604332 16640825 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
3.88 | 16904648 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.26 | 16983495 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.27 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.81 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
6.68 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Fenretinide |
6.68 | 16187019 |
MESH:D005922 |
Glomerulonephritis, IGA |
|
deoxynivalenol |
4.69 | 15173396 16524712 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.66 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.18 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Methotrexate |
4.75 | 16518429 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Cisplatin |
7.12 | 15102660 15464296 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
7.12 | 15692506 |
MESH:D034381 |
Hearing Loss |
|
Cisplatin |
3.96 | 19898482 |
MESH:D006319 |
Hearing Loss, Sensorineural |
|
Cisplatin |
4.09 | 15464296 |
MESH:D006330 |
Heart Defects, Congenital |
|
Ascorbic Acid |
9.91 | 16080930 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
9.91 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
9.91 | 11294989 10048152 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.20 | 12587719 18006777 17888722 16244372 16144979 16879835 18674790 14766674 16244371 16495754 16330681 17875725 16707910 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.09 | 17481944 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.54 | 15692506 |
MESH:D006432 |
Hemochromatosis |
|
Iron |
4.19 | 17255318 16574947 17236123 16604332 16640825 17053826 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.01 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.97 | 11000095 |
MESH:D006486 |
Hemosiderosis |
|
Iron |
4.80 | 16604332 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.13 | 6705139 |
MESH:D006525 |
Hepatitis, Viral, Human |
|
Iron |
5.05 | 16640825 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Iron |
4.54 | 17182432 |
MESH:D006529 |
Hepatomegaly |
|
Iron |
12.27 | 16890145 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
12.27 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
12.27 | 16120746 15340226 12621046 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Ascorbic Acid |
3.32 | 16490937 16863852 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.62 | 15709030 |
MESH:D015658 |
HIV Infections |
|
Iron |
3.45 | 16597321 |
MESH:D006689 |
Hodgkin Disease |
|
Cisplatin |
10.38 | 16200630 16170182 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
10.38 | 18501091 17606976 15147373 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
10.38 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.34 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.63 | 8697196 16959395 15340226 18606429 16354765 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.38 | 16870215 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.54 | 15034207 |
MESH:D006968 |
Hypersensitivity, Delayed |
|
Corn Oil |
5.40 | 11484837 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
4.39 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.39 | 18850075 18670907 |
MESH:D007006 |
Hypogonadism |
|
Iron |
4.11 | 16640825 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.41 | 16945680 16569931 |
MESH:D007037 |
Hypothyroidism |
|
Iron |
4.68 | 16640825 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.00 | 15869954 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.09 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
5.73 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
5.73 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Mustard Gas |
7.08 | 9260866 11428647 11428620 9357497 8975870 11402378 17524151 11428631 16001271 |
MESH:D007249 |
Inflammation |
|
Progesterone |
7.08 | 15869954 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
7.08 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
6.54 | 16627594 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
6.54 | 14714311 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Iron |
4.66 | 17163184 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.60 | 9022650 8074119 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
2.97 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.03 | 15604871 |
MESH:D007673 |
Kidney Cortex Necrosis |
|
Cisplatin |
4.73 | 15464296 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
25.15 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium Chloride |
25.15 | 16962696 |
MESH:D007674 |
Kidney Diseases |
|
Cisplatin |
25.15 | 12649298 19839026 12231392 18289764 15190930 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
25.15 | 18776723 10903974 8314463 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
25.15 | 16775033 15699352 15369732 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
25.15 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
25.15 | 20008137 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
3.79 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
10.46 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
10.46 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
10.46 | 15610895 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Cisplatin |
4.38 | 11231351 |
MESH:D007805 |
Language Development Disorders |
|
Methotrexate |
4.73 | 9562676 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
2.62 | 15070760 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
4.74 | 16085563 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.43 | 12560223 17077332 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
3.90 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.13 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
3.40 | 19077051 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
2.07 | 19850784 16467208 16968895 20471514 17050201 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
2.95 | 17649720 15622746 11468182 19225113 16112521 11161223 19075265 12018890 16823087 16891316 17712046 16331271 17107899 17217047 9834237 15748426 16330433 17869043 12712474 12679006 19035177 15336539 19642359 15213294 16966277 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
3.97 | 16882451 |
MESH:D007972 |
Leukoplakia, Oral |
|
Fenretinide |
5.63 | 16707609 |
MESH:D020961 |
Lewy Body Disease |
|
Iron |
5.03 | 16563566 |
MESH:D008103 |
Liver Cirrhosis |
|
arsenite |
13.96 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Iron |
13.96 | 16640825 |
MESH:D008103 |
Liver Cirrhosis |
|
Methotrexate |
13.96 | 14986274 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
13.96 | 21047994 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
2.94 | 9327722 15034207 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
4.59 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
4.59 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Metals, Heavy |
4.59 | 15383259 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
4.59 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
3.54 | 19460945 16611625 19784758 12587719 12969438 16610002 19014921 11587558 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
3.54 | 19363144 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Iron |
4.61 | 17207112 16737972 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
2.88 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
19.32 | 15890375 9163691 2125692 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
19.32 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
19.32 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Iron |
19.32 | 16640825 20302851 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
19.32 | 19812893 21047994 8742319 19073162 19482888 15975961 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
19.32 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
19.32 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
24.30 | 598648 3712494 6587162 1399818 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
24.30 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
24.30 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Ascorbic Acid |
24.30 | 18544905 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
24.30 | 17085340 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
24.30 | 1399818 2563599 17172636 6150874 18308698 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
24.30 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.04 | 15213294 |
MESH:D008171 |
Lung Diseases |
|
Ascorbic Acid |
10.88 | 16863852 |
MESH:D008171 |
Lung Diseases |
|
Mustard Gas |
10.88 | 18702808 18161513 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
10.88 | 19095001 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Methotrexate |
4.61 | 18516814 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
3.63 | 17365036 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
19.11 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
19.11 | 19825857 11798837 |
MESH:D008175 |
Lung Neoplasms |
|
arsenite |
19.11 | 16809336 |
MESH:D008175 |
Lung Neoplasms |
|
Ascorbic Acid |
19.11 | 16401635 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
19.11 | 20135361 18569708 18520028 20464547 20869020 18816296 17053015 6695378 20064080 |
MESH:D008175 |
Lung Neoplasms |
|
Cisplatin |
19.11 | 6189445 11798837 17225452 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
19.11 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Iron |
19.11 | 16640825 |
MESH:D008175 |
Lung Neoplasms |
|
Mustard Gas |
19.11 | 8781369 3148597 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
19.11 | 17077188 16712894 15276417 17306315 19931552 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
19.11 | 19555203 11884234 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
6.95 | 16098063 |
MESH:D008223 |
Lymphoma |
|
Methotrexate |
6.95 | 17352296 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
3.68 | 14737004 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.46 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.17 | 15621674 |
MESH:D008268 |
Macular Degeneration |
|
Iron |
3.75 | 16640825 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
12.15 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
12.15 | 11807958 16891317 11408345 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Fenretinide |
12.15 | 10697514 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
12.15 | 11408345 17203775 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.07 | 19453300 |
MESH:D008545 |
Melanoma |
|
Cisplatin |
6.67 | 18505091 16248763 18176117 17023156 16432458 17761969 12374674 16809738 18332650 11135225 12883367 15577323 12393984 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
6.67 | 16827129 |
MESH:D008545 |
Melanoma |
|
Fenretinide |
6.67 | 16270382 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
6.67 | 19082730 16487513 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Cisplatin |
4.37 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.17 | 19513568 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
9.31 | 16166281 16966607 18303189 |
MESH:D008654 |
Mesothelioma |
|
Cisplatin |
9.31 | 17638057 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
9.31 | 17638057 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.37 | 16801185 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.13 | 15792986 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
7.75 | 16381670 |
MESH:D009062 |
Mouth Neoplasms |
|
Fenretinide |
7.75 | 16274795 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
11.16 | 17415656 |
MESH:D052016 |
Mucositis |
|
Methotrexate |
11.16 | 17488658 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
2.82 | 19549372 19417148 15949261 14977855 11468182 |
MESH:D020528 |
Multiple Sclerosis, Chronic Progressive |
|
Iron |
5.26 | 17086897 |
MESH:D009181 |
Mycoses |
|
Iron |
5.05 | 16640825 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.26 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
2.90 | 16105982 16882451 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
2.77 | 15857846 19429709 |
MESH:D017202 |
Myocardial Ischemia |
|
Iron |
8.10 | 16604332 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
8.10 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
7.70 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Iron |
7.70 | 16604332 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.07 | 17484760 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
3.57 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
5.26 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
5.26 | 18259882 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
13.52 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Cisplatin |
13.52 | 16773208 |
MESH:D009369 |
Neoplasms |
|
Fenretinide |
13.52 | 17353921 15958647 |
MESH:D009369 |
Neoplasms |
|
lycopene |
13.52 | 17051425 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
13.52 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.27 | 20056578 |
MESH:D009389 |
Neovascularization, Pathologic |
|
arsenite |
8.80 | 15738583 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
8.80 | 17289903 |
MESH:D009395 |
Nephritis, Interstitial |
|
Cisplatin |
4.08 | 15464296 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.37 | 16899518 16636307 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.03 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
13.84 | 18481113 19348381 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
13.84 | 16889571 15640375 |
MESH:D009404 |
Nephrotic Syndrome |
|
Iron |
13.84 | 17178036 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
8.18 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
8.18 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
10.58 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
10.58 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
10.58 | 12854658 |
MESH:D009447 |
Neuroblastoma |
|
Cisplatin |
6.42 | 8761367 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
6.42 | 15555623 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
7.42 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Iron |
7.42 | 17296847 16604332 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cisplatin |
4.29 | 8761367 |
MESH:D009472 |
Neuronal Ceroid-Lipofuscinoses |
|
Fenretinide |
5.27 | 16303764 |
MESH:D009503 |
Neutropenia |
|
Mustard Gas |
3.60 | 16761898 7688884 |
MESH:D009765 |
Obesity |
|
Ascorbic Acid |
3.04 | 17217161 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
3.07 | 4026338 6482804 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.60 | 3988306 |
MESH:D010003 |
Osteoarthritis |
|
Iron |
3.72 | 16640825 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
3.96 | 17016548 |
MESH:D010024 |
Osteoporosis |
|
Iron |
3.61 | 16640825 16648989 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.79 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
17.02 | 19769630 16624393 12452020 |
MESH:D010051 |
Ovarian Neoplasms |
|
Cisplatin |
17.02 | 19769630 17225452 6897625 15464296 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
17.02 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Fenretinide |
17.02 | 16133793 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
17.02 | 16525653 17393432 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
17.02 | 17306315 15276417 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.08 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
11.08 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cisplatin |
11.08 | 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fenretinide |
11.08 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
11.08 | 16965848 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.31 | 11578682 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
8.15 | 7296757 |
MESH:D010212 |
Papilloma |
|
Iron |
8.15 | 12065085 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
3.79 | 19927285 |
MESH:D020447 |
Parasomnias |
|
Iron |
5.60 | 17352947 |
MESH:D010300 |
Parkinson Disease |
|
Iron |
3.17 | 16640825 16563566 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.83 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Cisplatin |
3.92 | 15464296 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.06 | 6228378 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
4.74 | 17983394 |
MESH:D010900 |
Pituitary Diseases |
|
Iron |
5.26 | 16604332 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
4.50 | 10923243 |
MESH:D010997 |
Pleural Neoplasms |
|
Cisplatin |
12.55 | 17638057 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
12.55 | 17638057 |
MESH:D011041 |
Poisoning |
|
Iron |
7.76 | 16604332 |
MESH:D011041 |
Poisoning |
|
Mustard Gas |
7.76 | 15727166 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Iron |
9.74 | 16640825 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
9.74 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Corn Oil |
13.50 | 14668109 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
13.50 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
13.50 | 2563599 |
MESH:D011225 |
Pre-Eclampsia |
|
Iron |
4.11 | 16640825 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
2.79 | 11896295 11222880 11118676 11399792 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.52 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
2.34 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.34 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
2.34 | 16888761 16729912 16868541 18437689 15749863 15897917 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.34 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fenretinide |
2.34 | 17024972 |
MESH:D011471 |
Prostatic Neoplasms |
|
lycopene |
2.34 | 15084515 17337101 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.34 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
2.34 | 18760546 |
MESH:D011528 |
Protozoan Infections |
|
Iron |
5.60 | 16640825 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
8.17 | 15861022 16919318 |
MESH:D011537 |
Pruritus |
|
Mustard Gas |
8.17 | 18058305 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
4.08 | 12752131 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
5.39 | 16882103 |
MESH:D011565 |
Psoriasis |
|
Methotrexate |
5.39 | 17410198 |
MESH:D011657 |
Pulmonary Eosinophilia |
|
Ascorbic Acid |
4.92 | 14606601 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
5.35 | 17975199 17365031 17322281 15814490 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Mustard Gas |
5.35 | 10334151 17894541 17620002 17266442 17720292 |
MESH:D051437 |
Renal Insufficiency |
|
Cisplatin |
14.96 | 15464296 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
14.96 | 17922066 |
MESH:D051437 |
Renal Insufficiency |
|
Methotrexate |
14.96 | 17352296 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.45 | 18990726 |
MESH:D012148 |
Restless Legs Syndrome |
|
Iron |
4.24 | 16930377 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
8.10 | 3692021 |
MESH:D012162 |
Retinal Degeneration |
|
Fenretinide |
8.10 | 16303925 |
MESH:D012174 |
Retinitis Pigmentosa |
|
Ascorbic Acid |
3.19 | 16849425 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.70 | 18045962 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.64 | 16767912 17710206 15625365 15675481 18313854 17203757 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
15.05 | 16646077 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Cisplatin |
15.05 | 14601052 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
15.05 | 14601052 16326096 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.38 | 17846226 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
2.43 | 3137016 4039156 16876388 11442880 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.41 | 6407741 |
MESH:D012871 |
Skin Diseases |
|
Ascorbic Acid |
4.91 | 18709164 |
MESH:D012871 |
Skin Diseases |
|
Mustard Gas |
4.91 | 15451306 12880345 16961503 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
24.11 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
24.11 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Fenretinide |
24.11 | 16467112 |
MESH:D012878 |
Skin Neoplasms |
|
Iron |
24.11 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
24.11 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
24.11 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
24.11 | 16192470 |
MESH:D055752 |
Small Cell Lung Carcinoma |
|
Cisplatin |
4.93 | 15464296 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.17 | 17203757 16767912 15625365 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.53 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
3.87 | 16503802 15862959 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.48 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
4.36 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
4.36 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
Cisplatin |
4.36 | 17522103 18396642 15958060 |
MESH:D013274 |
Stomach Neoplasms |
|
nitrosobenzylmethylamine |
4.36 | 17575124 12958204 |
MESH:D013276 |
Stomach Ulcer |
|
Ascorbic Acid |
3.54 | 18726076 |
MESH:D020521 |
Stroke |
|
Ascorbic Acid |
3.97 | 16403987 16517955 |
MESH:D013398 |
Sudden Infant Death |
|
Iron |
5.04 | 16640825 |
MESH:D013576 |
Syndactyly |
|
Methotrexate |
4.65 | 9562676 |
MESH:D013736 |
Testicular Neoplasms |
|
Cisplatin |
4.26 | 15464296 17225452 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.25 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.81 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.49 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
14.58 | 6587162 6582329 3712494 1399818 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
14.58 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
14.58 | 17909728 16010429 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
14.58 | 1399818 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.27 | 19048282 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.56 | 15213294 |
MESH:D014376 |
Tuberculosis |
|
Iron |
3.83 | 16597321 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
21.50 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
21.50 | 20435036 12845720 11780464 12973940 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
21.50 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cisplatin |
21.50 | 15464296 12973940 17225452 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
21.50 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Fenretinide |
21.50 | 16720286 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
21.50 | 16452187 11723127 16712894 17306315 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.61 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Cisplatin |
13.99 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fenretinide |
13.99 | 16154183 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
13.99 | 11813266 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
2.92 | 14692618 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.57 | 1336536 |
MESH:D014625 |
Vaginal Neoplasms |
|
Cisplatin |
4.21 | 15577323 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.02 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.18 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.18 | 14671159 15869587 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
3.83 | 17678736 17638931 17334414 16364871 |
MESH:D014839 |
Vomiting |
|
Cisplatin |
4.30 | 11897121 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.83 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.03 | 17120751 |